Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05363813Not ApplicableCompleted

Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery

Role: collaborator

NCT05073510Completed

Clinical Evaluation of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease

Role: collaborator

NCT05043883Not ApplicableCompleted

Automated Assessment of PVI Using a Novel EP Recording System

Role: collaborator

NCT04653662Not ApplicableCompleted

Earol Madrid Study

Role: collaborator

All 4 trials loaded